skip to Main Content


IMPORTANT: Temporary Suspension of Single Cell Genomics Core Services

Given the rapidly evolving COVID-19 pandemic and coordinated responses by Harvard Medical School, Partners HealthCare and the Brigham, we have been advised that our core facility remain closed until 5/22. We will also be suspending any future scheduling of experiments until further notice.

In the coming weeks, we will be monitoring the response and actions taken by these governing bodies and will provide updates via our core email list. If you’d like to be included on our email list for updates, please email:

We apologize for the anticipated strain that this puts on your research and for any cancellations that have to be made during this unprecedented situation.

Disease Deconstruction by Single Cell Transcriptomics:

 A new molecular pathology with single cell resolution

The advent of droplet-based single cell transcriptomic analysis now offers the ability to assess single cells from patient samples or animal models in dramatic detail and has the potential to identify new pathologic cell subsets and phenotypes that may be targeted therapeutically. The Single Cell Genomics Core offers researchers an integrated pipeline to perform successful single cell transcriptomic analysis, including droplet-based single cell transcriptome library preparation, sequencing, and bioinformatic analysis through the core, along with technical expertise on tissue processing, sample preparation, and cell isolation.

For more information, please email:

Back To Top